A Phase I Trial of a 5-Day Schedule of Intravenous Topotecan and Etoposide in Previously Untreated Patients with Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|61|1|25-29

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.1, 2001-09, pp. : 25-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Feasibility of Oral Topotecan in Previously Untreated Patients with Small-Cell Lung Cancer Ineligible for Standard Therapy

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Phase II Study of a 3-Week Schedule of Irinotecan Combined with Cisplatin in Previously Untreated Extensive-Stage Small-Cell Lung Cancer

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Phase II Trial of Weekly Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 224-228

Karger

Access to resources Recommend Favorite

Early Tandem High-Dose Ifosfamide, Carboplatin, Etoposide Therapy with Stem Cell Rescue for Small-Cell Lung Cancer: Brief Report on the Results of a Phase-I/II Trial

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 248-253

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 192-196

Karger

Access to resources Recommend Favorite